Katharina G. Mcfarland - Oct 20, 2023 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Oct 20, 2023
Transactions value $
$0
Form type
4
Date filed
10/24/2023, 04:14 PM
Previous filing
Oct 13, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +4.79K +5.39% $0.00 93.7K Oct 20, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU") that was fully vested as of the grant date. The RSUs were automatically granted to the Reporting Person pursuant to the Issuer's Outside Director Compensation Policy in lieu of cash fees for service during the quarter ended September 30, 2023.